Our offerings are designed to inform key commercialization decisions.
Phase 1/2 of Clinical Development
How big is our market?
Epidemiology / Sizing
“Water-fall” slides estimating accessible opportunity and “leakages” in each leverage point
Robust estimates of dynamic (e.g., incidence) and static (e.g., prevalence) patient pools
Population modeling to understand long-term trends, impact of anticipated shifts
How we derive deeper insights
We integrate multiple data sources and are knowledgeable about each individual dataset's limitations and the ways of overcoming them
We leverage our patient flow modeling platform to develop Disease Natural History Models to cross-validate epi estimates and create a non-conflicting view of TA evolution
Phase 1/2 of Clinical Development
Where should we focus?
Patient Journey
Diagram describing the entire care continuum and highlighting important factors influencing care and outcomes
Prioritized list of influence points, behavioral objectives and drivers / barriers for our brand
How we derive deeper insights
We go beyond simply diagramming to quantify the key elements of the journey
We integrate insights from quant (e.g., claims, charts, etc.) and qual (e.g., emotional journey)
We develop multiple versions, e.g., highly-detailed and quantified (for market researchers), as well as high-level visual infographics (for leadership, publications, etc.)
Phase 1/2 of Clinical Development
What drives treatment choice?
Decision Hierarchy Analysis
Statistical data mining analysis to identify drivers of choice and key patient types treated differently
Decision algorithm based on the most important characteristics influencing treatment selection
How we derive deeper insights
We use multiple algorithms and validate decision logic and resulting patient types with qual. research and feedback from Medical
ViewFinder™ research platform enables us to analyze current and future decision making
We create effective diagrams communicating key insights in an intuitive story-telling format
Phase 3 of Clinical Development
Market Map
Decision Hierarchy Analysis
Clear, actionable and enduring “bird's-eye” view of the opportunity space and playing fields available to our drug
How we derive deeper insights
Optimal market map design combines data-derived drivers with qual. insights and strategic thinking from the brand team
ViewFinder™ research platform enables us to populate the map with projected sizes and overlay our drug's ability to win
Phase 3 of Clinical Development
Who do we target?
Targeting
Identifying the best customers for promotional activity – prescribers and/or accounts
Customized plans for different tactics – sales force effort, digital activities, and other promotional activities
Mix and frequency of activities by customer
How we derive deeper insights
We find true underlying opportunity by considering promotion response and:
Underlying patient opportunity
Competitive prescribing
Managed care and IDN favorability/control
We maximize impact by incorporating all key drivers and barriers of sales, and providing practical recommendations
Phase 3 of Clinical Development
What's our peak share?
Demand Study
Preference share
Share validation and discounting
Sensitivity to scenarios
Source of business / regimens displaced
Optimal sequencing
Drivers / barriers
Target patient and physician types
User-friendly simulator
How we derive deeper insights
We have developed proprietary chart-based TPP exposure and testing methodologies which result in robust and realistic estimates of clinical preference and deep understanding of what is driving the share
ShareCaster™ research platform enables us to accommodate a large range of scenarios and conjoint designs without fatiguing respondents and compromising the quality of the data
Phase 3 of Clinical Development
What's our forecast?
Forecast Model
Short- and long-range unit and revenue estimates with ability to adjust key inputs/assumptions and assess alternative scenarios
How we derive deeper insights
At the core of our forecasts is a custom-designed patient flow model simulating key market dynamics and calibrated to historical trends observed in secondary data
Pre-Launch / Launch / Inline
How do we track our launch?
SAPPHIRE™ platform
Continuously running comprehensive tracking platform consisting of three modules:
ATU module (awareness / perceptions)
Charts module (share / behaviors)
Rep module (sales force effectiveness)
How we derive deeper insights
We align KPIs logically to the adoption cascade to enable timely identification of bottlenecks post-launch
We use statistical data-mining to understand what drives key behaviors / KPIs
Pre-Launch / Launch / Inline
What drives adoption?
Promotion Response
Proven techniques that measure the true impact of traditional and digital promotional activities:
Unbiased results
Detailed and actionable
MAC Optimizer tool with sensitivity analysis
How we derive deeper insights
We look deeper than just correlational relationships and seek the true causal relationships between promotional activities and sales
We account for key external drivers of sales using advanced AI techniques to understand what truly drives sales
